evidence table
Resveratrol Insulin Sensitivity Meta-Analysis Evidence Table
Structured evidence table for Resveratrol Insulin Sensitivity Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resveratrol Insulin Sensitivity Meta-Analysis | The main aim of this systematic review is to comprehensively evaluate and synthesize the current scientific evidence on the role of anthocyanins, curcumin, and resveratrol in the prevention and management of metabolic disorders, with a focus on obesity, type 2 diabetes, and dyslipidemia. | 1 | Gazda P (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review. |
| Resveratrol Insulin Sensitivity Meta-Analysis | The analyzed studies demonstrated that anthocyanin supplementation (up to 320 mg/day) was associated with reductions in inflammatory markers such as IL-6 and TNF-α, improvements in HDL cholesterol, and modest reductions in HbA1c (~0.3-0.5%). | 1 | Gazda P (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review. |
| Resveratrol Insulin Sensitivity Meta-Analysis | Curcumin supplementation was associated with decreases in body weight (up to 0.82 kg), BMI (up to 0.30 kg/m 2 ), triglycerides, total cholesterol, and fasting glucose levels. | 1 | Gazda P (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review. |
| Resveratrol Insulin Sensitivity Meta-Analysis | Metabolic disorders such as obesity, type 2 diabetes, and lipid disorders are major health challenges worldwide. | 1 | Gazda P (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review. |
| Resveratrol Insulin Sensitivity Meta-Analysis | 3 4 3 5 Resveratrol is a naturally occurring polyphenolic compound found in various plants, including grapes, berries, and peanuts. | 1 | Meden Ana (2026) | Resveratrol in diabetes and pancreatic function: implications for the exocrine–endocrine pancreatic axis–a systematic review |
| Resveratrol Insulin Sensitivity Meta-Analysis | However, most available evidence originates from studies focusing on metabolic forms of diabetes rather than pancreatic disease-related diabetes (,–). | 1 | Meden Ana (2026) | Resveratrol in diabetes and pancreatic function: implications for the exocrine–endocrine pancreatic axis–a systematic review |
| Resveratrol Insulin Sensitivity Meta-Analysis | The aim of this systematic review is therefore to synthesize available evidence on the metabolic and pancreatic effects of resveratrol in diabetes mellitus. | 1 | Meden Ana (2026) | Resveratrol in diabetes and pancreatic function: implications for the exocrine–endocrine pancreatic axis–a systematic review |
| Resveratrol Insulin Sensitivity Meta-Analysis | 1 2 Pancreatogenic diabetes mellitus (PDM), also referred to as type 3c diabetes, is a form of diabetes resulting from diseases of the exocrine pancreas. | 1 | Meden Ana (2026) | Resveratrol in diabetes and pancreatic function: implications for the exocrine–endocrine pancreatic axis–a systematic review |
Source documents